The findings of this research could help provide stroke survivors and their relatives with more accurate information about what impacts they can expect over time and will help doctors and therapists identify which patients with visual neglect will benefit the most from new treatments.
A stroke is not something you prepare for. So you’re going to have a lot of questions when it happens. That’s why we’re here. We’ve tackled some of the questions that you're likely to have, including details of how to find out more.
Find out more about the different types of stroke and why they happen.
The number of strokes across the UK is likely to rise by almost half (44%) in the next 20 years, according to a new report published today by the Stroke Alliance for Europe (SAFE) and the Stroke Association.
This research is about bleeding (haemorrhage) in the brain caused by bursting (rupture) of an abnormal swelling (aneurysm) – causing a devastating form of stroke known as subarachnoid haemorrhage (SAH).
Existing vision tests do not tell us how a patient’s life will be influenced by their vision problems. This project aims to understand how the results of vision tests relate to how stroke survivors will be able to function in their daily lives.
What can you expect when you start your recovery in hospital? This section covers the move from acute care to rehabilitation in hospitals, introduces the multi-disciplinary team of stroke that will help with your recovery, and provide information on starting rehabilitation therapy. It also looks at the question of whether you will fully recover from your stroke.
Co-funded by the Stroke Association, and published in the International Journal of Stroke, research suggests a new tool can better predict what level of memory and thinking (cognitive) problems patients will experience after stroke, than more time consuming methods.
The CROMIS-2 study investigated whether signs of small brain bleeds on routine brain scans can help us understand which ischaemic stroke patients with atrial fibrillation are at increased risk of a bleed in the brain when on anticoagulant ‘blood thinning’ drugs.